Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents

• Daniel A. Ladin,
• Eman Soliman,
• Eman Soliman,
• LaToya Griffin,
• Rukiyah Van Dross,
• Rukiyah Van Dross

Affiliations

Daniel A. Ladin

Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States

Eman Soliman

Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States

Eman Soliman

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt

LaToya Griffin

Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States

Rukiyah Van Dross

Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States

Rukiyah Van Dross

Center for Health Disparities, East Carolina University, Greenville, NC, United States